Autoregulation of 5-fluorouracil metabolism (Q28579293)

31 January 2017

title

Autoregulation of 5-fluorouracil metabolism (English)

1 reference

31 January 2017

1 reference

H. L. McLeod

1

1 reference

31 January 2017

J. Sludden

2

1 reference

31 January 2017

S. C. Hardy

3

1 reference

31 January 2017

R. E. Lock

4

1 reference

31 January 2017

G. M. Hawksworth

5

1 reference

31 January 2017

J. Cassidy

6

1 reference

31 January 2017

publication date

1 September 1998

1 reference

European Journal of Cancer

31 January 2017

published in

1 reference

31 January 2017

volume

34

1 reference

31 January 2017

issue

10

1 reference

31 January 2017

page(s)

1623–1627

1 reference

Diagnostic analysis, clinical importance and molecular basis of dihydropyrimidine dehydrogenase deficiency

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900175-0

7 January 2021

Clinical pharmacology of 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900175-0

7 January 2021

Relationship between fluorouracil systemic exposure and tumor response and patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900175-0

7 January 2021

Pharmacokinetic and pharmacodynamic analysis of fluorouracil during 72-hour continuous infusion with and without dipyridamole

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900175-0

7 January 2021

Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900175-0

7 January 2021

Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900175-0

7 January 2021

Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. A potentially more common pharmacogenetic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900175-0

7 January 2021

Analysis of the dihydropyrimidine dehydrogenase polymorphism in a British population

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900175-0

7 January 2021

Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900175-0

7 January 2021

Characterization of dihydropyrimidine dehydrogenase in human colorectal tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900175-0

7 January 2021

Circadian rhythm of rat liver dihydropyrimidine dehydrogenase. Possible relevance to fluoropyrimidine chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900175-0

7 January 2021

Spontaneous or imposed circadian changes in plasma concentrations of 5-fluorouracil coadministered with folinic acid and oxaliplatin: relationship with mucosal toxicity in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900175-0

7 January 2021

Role of Dihydropyrimidine Dehydrogenase in the Uridine Nucleotide Metabolism in the Rat Liver

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900175-0

7 January 2021

Effect of vitamin B2 deficiency on rat liver dihydropyrimidine dehydrogenase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900175-0

7 January 2021

The effect of dietary protein depletion on hepatic 5-fluorouracil metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900175-0

7 January 2021

The cellular interaction of 5-fluorouracil and cisplatin in a human colon carcinoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900175-0

7 January 2021

Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P-450.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900175-0

7 January 2021

Purification and characterization of liver microsomal cytochrome P-450 from untreated male rats

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900175-0

7 January 2021

A pharmacodynamic approach to the estimate of carbamazepine autoinduction.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900175-0

7 January 2021

Increased teniposide clearance with concomitant anticonvulsant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900175-0

7 January 2021

Rapid development of enhanced clearance after high-dose cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900175-0

7 January 2021

Effects of 5-fluorouracil treatment on rat liver microsomal enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900175-0

7 January 2021

The effect of cytotoxic agents on drug metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900175-0

7 January 2021

10.1016/S0959-8049(98)00175-0

Identifiers

DOI

0 references

1 reference